Acute pancreatitis explained

Acute pancreatitis
Synonyms:Acute pancreatic necrosis[1]
Field:Gastroenterology, general surgery

Acute pancreatitis (AP) is a sudden inflammation of the pancreas. Causes include a gallstone impacted in the common bile duct or the pancreatic duct, heavy alcohol use, systemic disease, trauma, elevated calcium levels, hypertriglyceridemia (with triglycerides usually being very elevated, over 1000 mg/dL), certain medications, hereditary causes and, in children, mumps. Acute pancreatitis may be a single event, it may be recurrent, or it may progress to chronic pancreatitis and/or pancreatic failure (the term pancreatic dysfunction includes cases of acute or chronic pancreatitis where the pancreas is measurably damaged, even if it has not failed).

In all cases of acute pancreatitis, early intravenous fluid hydration and early enteral (nutrition delivered to the gut, either by mouth or via a feeding tube) feeding are associated with lower mortality and complications.[2] Mild cases are usually successfully treated with conservative measures such as hospitalization with intravenous fluid infusion, pain control, and early enteral feeding. If a person is not able to tolerate feeding by mouth, feeding via nasogastric or nasojejunal tubes are frequently used which provide nutrition directly to the stomach or intestines respectively. Severe cases often require admission to an intensive care unit. Severe pancreatitis, which by definition includes organ damage other than the pancreas, is associated with a mortality rate of 20%. The condition is characterized by the pancreas secreting active enzymes such as trypsin, chymotrypsin and carboxypeptidase, instead of their inactive forms, leading to auto-digestion of the pancreas. Calcium helps to convert trypsinogen to the active trypsin, thus elevated calcium (of any cause) is a potential cause of pancreatitis. Damage to the pancreatic ducts can occur as a result of this. Long term complications include type 3c diabetes (pancreatogenic diabetes), in which the pancreas is unable to secrete enough insulin due to structural damage. 35% develop exocrine pancreatic insufficiency in which the pancreas is unable to secrete digestive enzymes due to structural damage, leading to malabsorption.

Signs and symptoms

Common

Common symptoms of acute pancreatitis include abdominal pain, nausea, vomiting, and low to moderate grade fever.[3] The abdominal pain is the most common symptom and it is usually described as being in the left upper quadrant, epigastric area or around the umbilicus, with radiation throughout the abdomen, or to the chest or back.[4] The abdominal pain initially may worsen with eating or drinking but may become constant as the disease progresses. Less common symptoms include hiccups, abdominal bloating and indigestion. Although these are common symptoms, frequently they are not all present; and epigastric pain may be the only symptom.[5]

Grey-Turner's sign (hemorrhagic discoloration of the flanks) or Cullen's sign (hemorrhagic discoloration of the umbilicus) are associated with severe disease. However both signs are rare (occurring in less than 1% of cases of acute pancreatitis) and are not specific nor sensitive for diagnosis of acute pancreatitis.[6] Pleural effusions (fluid in the lung cavity) may occur in up to 34% of people with acute pancreatitis and are associated with a poor prognosis.[7] The Mayo-Robson's sign (pain while pressing at the top of the angle lateral to the erector spinae muscles and below the left 12th rib (left costovertebral angle (CVA)) is also associated with acute pancreatitis.[8]

Complications

Complications of acute pancreatitis may occur. Necrotic pancreatitis occurs when inflammation of the pancreas progresses to cell death. Acute fluid collections may form adjacent to the pancreas or necrotic collections (discrete areas of dead tissue) may also form adjacent to or within the pancreas. These may progress to pancreatic pseudocysts and walled off areas of dead tissue which may persist for longer than 4 weeks. Both can become secondarily infected. Other complications include gastric outlet obstruction splenic artery pseudoaneurysms, hemorrhage from erosions into splenic artery and vein, blood clot of the splenic vein, superior mesenteric vein and portal veins, duodenal obstruction, common bile duct obstruction, progression to chronic pancreatitis, pancreatic ascites, or pleural effusion.[9]

Systemic complications include acute respiratory distress syndrome (ARDS), multiple organ dysfunction syndrome, disseminated intravascular coagulation (DIC), hypocalcemia (from fat saponification), hyperglycemia and insulin dependent diabetes mellitus (from pancreatic insulin-producing beta cell damage), and malabsorption due to exocrine failure.

Tobacco use, recurrent episodes of acute pancreatitis, pancreatic tissue death, alcoholic pancreatitis are all risk factors for developing chronic pancreatitis.

Causes

Most common

Less common

Pathology

Pathogenesis

Acute pancreatitis occurs when there is abnormal activation of digestive enzymes within the pancreas. This occurs through inappropriate activation of inactive enzyme precursors called zymogens (or proenzymes) inside the pancreas, most notably trypsinogen. Normally, trypsinogen is converted to its active form (trypsin) in the first part of the small intestine (duodenum), where the enzyme assists in the digestion of proteins. During an episode of acute pancreatitis, trypsinogen comes into contact with lysosomal enzymes (specifically cathepsin), which activate trypsinogen to trypsin. The active form trypsin then leads to further activation of other molecules of trypsinogen. The activation of these digestive enzymes lead to inflammation, edema, vascular injury, and even cellular death. The death of pancreatic cells occurs via two main mechanisms: apoptosis, which is physiologically controlled, and necrosis, which is less organized and more damaging. The balance between these two mechanisms of cellular death is mediated by caspases which regulate apoptosis and have important anti-necrosis functions during pancreatitis: preventing trypsinogen activation, preventing ATP depletion through inhibiting polyADP-ribose polymerase, and by inhibiting the inhibitors of apoptosis (IAPs). If, however, the caspases are depleted due to either chronic ethanol exposure or through a severe insult then necrosis can predominate.

Pathophysiology

The two types of acute pancreatitis are mild and severe, which are defined based on whether the predominant response to cell injury is inflammation (mild) or necrosis (severe). In mild pancreatitis, there is inflammation and edema of the pancreas. In severe pancreatitis, there is necrosis of the pancreas, and nearby organs may become injured.

As part of the initial injury there is an extensive inflammatory response due to pancreatic cells synthesizing and secreting inflammatory mediators: primarily TNF-alpha and IL-1. A hallmark of acute pancreatitis is a manifestation of the inflammatory response, namely the recruitment of neutrophils to the pancreas. The inflammatory response leads to the secondary manifestations of pancreatitis: hypovolemia from capillary permeability, acute respiratory distress syndrome, disseminated intravascular coagulations, renal failure, cardiovascular failure, and gastrointestinal hemorrhage.

Histopathology

The acute pancreatitis (acute hemorrhagic pancreatic necrosis) is characterized by acute inflammation and necrosis of pancreas parenchyma, focal enzymic necrosis of pancreatic fat and vessel necrosis (hemorrhage). These are produced by intrapancreatic activation of pancreatic enzymes. Lipase activation produces the necrosis of fat tissue in pancreatic interstitium and peripancreatic spaces as well as vessel damage. Necrotic fat cells appear as shadows, contours of cells, lacking the nucleus, pink, finely granular cytoplasm. It is possible to find calcium precipitates . Digestion of vascular walls results in thrombosis and hemorrhage. Inflammatory infiltrate is rich in neutrophils. Due to the pancreas lacking a capsule, the inflammation and necrosis can extend to include fascial layers in the immediate vicinity of the pancreas.

Diagnosis

Acute pancreatitis is diagnosed using clinical history and physical examination findings supporting the diagnosis with imaging and pancreatic enzymes (amylase and lipase). The Revised Atlanta Classification requires two out of three of the following findings for the diagnosis: abdominal pain consistent with pancreatitis, elevated amylase or lipase levels greater than 3 times the upper limit of normal, and imaging consistent with acute pancreatitis.[13] Additional labs may be used to identify organ failure for prognostic purposes or to guide fluid resuscitation rate. If the lipase level is about 2.5 to 3 times that of amylase, it is an indication of pancreatitis due to alcohol.[14] Serum lipase is more sensitive and specific than serum amylase in the diagnosis of acute pancreatitis, and is the preferred test in the diagnosis.[15] [16]

Most, but not all individual studies support favor the diagnostic utility of lipase.[17] In one large study, there were no patients with pancreatitis who had an elevated amylase with a normal lipase.[18] Another study found that the amylase could add diagnostic value to the lipase, but only if the results of the two tests were combined with a discriminant function equation.[19]

Reduced lipase clearance due to kidney disease, gastrointestinal or hepatobiliary cancers, pancreatic enzyme hypersecretion, critical illness including due to neurosurgical causes have been shown to increase serum lipase and may complicate the diagnosis of acute pancreatitis.[20]

Differential diagnosis

The differential diagnosis includes:[21]

Computed tomography

Regarding the need for computed tomography, practice guidelines state:

CT is an important common initial assessment tool for acute pancreatitis. Imaging is indicated during the initial presentation if:

CT is recommended as a delayed assessment tool in the following situations:

Abdominal CT should not be performed before the first 12 hours of onset of symptoms as early CT (<12 hours) may result in equivocal or normal findings.

CT findings can be classified into the following categories for easy recall:

The principal value of CT imaging to the treating clinician is the capacity to identify devitalized areas of the pancreas which have become necrotic due to ischaemia. Pancreatic necrosis can be reliably identified by intravenous contrast-enhanced CT imaging,[22] and is of value if infection occurs and surgical or percutaneous debridement is indicated.

Magnetic resonance imaging

While computed tomography is considered the gold standard in diagnostic imaging for acute pancreatitis,[23] magnetic resonance imaging (MRI) has become increasingly valuable as a tool for the visualization of the pancreas, particularly of pancreatic fluid collections and necrotized debris.[24] Additional utility of MRI includes its indication for imaging of patients with an allergy to CT's contrast material, and an overall greater sensitivity to hemorrhage, vascular complications, pseudoaneurysms, and venous thrombosis.[25]

Another advantage of MRI is its utilization of magnetic resonance cholangiopancreatography (MRCP) sequences. MRCP provides useful information regarding the etiology of acute pancreatitis, i.e., the presence of tiny biliary stones (choledocholithiasis or cholelithiasis) and duct anomalies. Clinical trials indicate that MRCP can be as effective a diagnostic tool for acute pancreatitis with biliary etiology as endoscopic retrograde cholangiopancreatography, but with the benefits of being less invasive and causing fewer complications.[26] [27]

Ultrasound

Ultrasound is less preferred as a diagnostic test for acute pancreatitis, but it may be used in select cases. Abdominal ultrasonography may be obtained if there is concern of a gallstone blocking the pancreatic duct leading to pancreatitis.

Treatment

Early enteral (nutrition given directly to the gut, either by mouth or via feeding tube) nutrition and aggressive intravenous fluid hydration are indicated in all forms and severities of acute pancreatitis and are associated with lower mortality and complications.

Fluid replacement

The specific rate of intravenous fluid replacement in acute pancreatitis is not well established but some experts recommend an initial fluid infusion rate of 5-10 mL of IV fluids per kilogram of body weight per hour and adjusting the rate to meet physiologic parameters such as heart rate, mean arterial pressure, urine output and hematocrit.

Isotonic crystalloid solutions (such as lactated ringers) are preferred over normal saline for fluid resuscitation and are associted with a lower risk of developing systemic inflammatory response syndrome (SIRS).

In the initial stages (within the first 12 to 24 hours) of acute pancreatitis, fluid replacement has been associated with a reduction in morbidity and mortality.[28] [29] [30] [31]

Pain control

Abdominal pain is often the predominant symptom in patients with acute pancreatitis and should be treated with analgesics.

Opioids are safe and effective at providing pain control in patients with acute pancreatitis.[32] Adequate pain control requires the use of intravenous opiates, usually in the form of a patient-controlled analgesia pump. Hydromorphone or fentanyl (intravenous) may be used for pain relief in acute pancreatitis. Fentanyl is being increasingly used due to its better safety profile, especially in renal impairment. As with other opiates, fentanyl can depress respiratory function. It can be given both as a bolus as well as constant infusion.Meperidine has been historically favored over morphine because of the belief that morphine caused an increase in sphincter of Oddi pressure. However, no clinical studies suggest that morphine can aggravate or cause pancreatitis or cholecystitis.[33] In addition, meperidine has a short half-life and repeated doses can lead to accumulation of the metabolite normeperidine, which causes neuromuscular side effects and, rarely, seizures.

Nutritional support

Acute pancreatitis is a catabolic state and with hemodynamic instability or fluid shifts or edema there may be reduced intravascular perfusion to the gut. This reduction in gut perfusion increases the risk of gut necrosis with bacterial translocation with the subsequent risk of sepsis or secondary infections. Enteral nutrition gives one needed caloric intake as well as enhances intestinal motility and blood flow to the gut, reducing these risks. Enteral nutrition (as compared to parenteral nutrition, in which nutrients are given via intravenous infusion) is associated with reduced mortality, reduced risk of multi-organ failure and systemic infection in those with acute pancreatitis.[34] In patients with acute pancreatitis, the American Gastroenterological Association (AGA) recommends early oral nutrition, within 24 hours, rather than keeping the patient fastng (or nothing by mouth). And in those unable to feed orally, the AGA recommends enteral nutrition (via a nasogastric or nasojejunal tube) rather than parenteral nutrition.[35]

Antibiotics

Up to 20 percent of people with acute pancreatitis develop an infection outside the pancreas such as bloodstream infections, pneumonia, or urinary tract infections.[36] These infections are associated with an increase in mortality.[37] Fluid collections around the pancreas or areas within the pancreas that experience tissue death (necrosis) may also become secondarily infected requiring the use of antibiotics. When an infection is suspected, antibiotics should be started while the source of the infection is being determined. However, if cultures are negative and no source of infection is identified, antibiotics should be discontinued.

Preventative antibiotics are not recommended in people with acute pancreatitis, regardless of the type (interstitial or necrotizing) or disease severity (mild, moderately severe, or severe)[13] [38]

Endoscopic retrograde cholangiopancreatography

In 30% of those with acute pancreatitis, no cause is identified. Endoscopic retrograde cholangiopancreatography (ERCP) with empirical biliary sphincterotomy has an equal chance of causing complications and treating the underlying cause, therefore, is not recommended for treating acute pancreatitis.[39] If a gallstone is detected, ERCP, performed within 24 to 72 hours of presentation with successful removal of the stone, is known to reduce morbidity and mortality.[40] The indications for early ERCP are:

The risks of ERCP are that it may worsen pancreatitis, it may introduce an infection to otherwise sterile pancreatitis, and bleeding.

Surgery

In those with mild acute pancreatitis due to gallstones, cholecystectomy (removal of the gallbladder) is recommended in the hospital and is associated with a reduced risk of pancreatitis recurrence. In those with gallstone pancreatitis who have severe disease, including the presence of peripancreatic fluid collections, cholecystectomy should be delayed as the fluid collections around the pancreas make surgery technically difficult. The peri-pancreatic fluids also carry a risk of becoming secondarily infected with surgery.

Surgery is indicated for (i) infected pancreatic necrosis and (ii) diagnostic uncertainty and (iii) complications. The most common cause of death in acute pancreatitis is secondary infection. Infection is diagnosed based on 2 criteria

Surgical options for infected necrosis include:

Other measures

Classification by severity: prognostic scoring systems

Acute pancreatitis patients recover in majority of cases. Some may develop abscess, pseudocyst or duodenal obstruction. About 20% of the acute pancreatitis are severe with a mortality of about 20%.Acute pancreatitis can be further divided into mild and severe pancreatitis. Several clinical scoring tools have been developed to determine prognostic information and may guide certain areas of clinical management, such as need for ICU admission.

Two such scoring systems are the Ranson criteria and APACHE II (Acute Physiology and Chronic Health Evaluation) indices. Most,[43] [44] but not all[45] studies report that the Apache score may be more accurate. In the negative study of the APACHE-II, the APACHE-II 24-hour score was used rather than the 48-hour score.Some experts recommend using the APACHE II score as well as a serum hematocrit level early during the admission as prognostic indicators.

Ranson score

See main article: Ranson criteria. The Ranson score is used to predict the severity of acute pancreatitis. They were introduced in 1974.

At admission

At 48 hours

The criteria for point assignment is that a certain breakpoint be met at any time during that 48 hour period, so that in some situations it can be calculated shortly after admission. It is applicable to both gallstone and alcoholic pancreatitis.

Alternatively, pancreatitis can be diagnosed by meeting any of the following:[2]

Alternative Ranson score

Ranson's score of ≥ 8Organ failureSubstantial pancreatic necrosis (at least 30% glandular necrosis according to contrast-enhanced CT)

InterpretationIf the score ≥ 3, severe pancreatitis likely.If the score < 3, severe pancreatitis is unlikelyOr

Score 0 to 2 : 2% mortalityScore 3 to 4 : 15% mortalityScore 5 to 6 : 40% mortalityScore 7 to 8 : 100% mortality

APACHE II score

See main article: APACHE II. "Acute Physiology And Chronic Health Evaluation" (APACHE II) score > 8 points predicts 11% to 18% mortality

Balthazar score

Developed in the early 1990s by Emil J. Balthazar et al.,[46] the Computed Tomography Severity Index (CTSI) is a grading system used to determine the severity of acute pancreatitis. The numerical CTSI has a maximum of ten points, and is the sum of the Balthazar grade points and pancreatic necrosis grade points:

Balthazar grade

Balthazar gradeAppearance on CTCT grade points
Grade ANormal CT0 points
Grade BFocal or diffuse enlargement of the pancreas1 point
Grade CPancreatic gland abnormalities and peripancreatic inflammation2 points
Grade DFluid collection in a single location3 points
Grade ETwo or more fluid collections and / or gas bubbles in or adjacent to pancreas4 points

Necrosis score

Necrosis percentage Points
No necrosis0 points
0 to 30% necrosis2 points
30 to 50% necrosis4 points
Over 50% necrosis6 points

CTSI's staging of acute pancreatitis severity has been shown by a number of studies to provide more accurate assessment than APACHE II, Ranson, and C-reactive protein (CRP) level.[47] [48] [49] However, a few studies indicate that CTSI is not significantly associated with the prognosis of hospitalization in patients with pancreatic necrosis, nor is it an accurate predictor of AP severity.[50] [51]

Glasgow score

The Glasgow score is valid for both gallstone and alcohol induced pancreatitis, whereas the Ranson score is only for alcohol induced pancreatitis. If a patient scores 3 or more it indicates severe pancreatitis and the patient should be considered for transfer to ITU. It is scored through the mnemonic, PANCREAS:

BISAP score

Predicts mortality risk in pancreatitis with fewer variables than Ranson's criteria. Data should be taken from the first 24 hours of the patient's evaluation.

Patients with a score of zero had a mortality of less than one percent, whereas patients with a score of five had a mortality rate of 22 percent. In the validation cohort, the BISAP score had similar test performance characteristics for predicting mortality as the APACHE II score.[52] As is a problem with many of the other scoring systems, the BISAP has not been validated for predicting outcomes such as length of hospital stay, need for ICU care, or need for intervention.

Epidemiology

The worldwide incidence of acute pancreatitis has increasing from 1961 to 2016 with an average annual percentage increase of 3%, the increased incidence was seen in North America and Europe.[53] The incidence of acute pancreatitis in the United States is 110-140 cases per 100,000 people.

In the United States the most common causes include gallstones, which are responsible for 21-33% of cases, followed by alcohol (16-27%) and elevated triglycerides (2-5%).

See also

External links

Notes and References

  1. Sommermeyer L . 10.2307/3412015 . Acute Pancreatitis . 3412015 . December 1935 . . 35 . 12 . 1157–1161 .
  2. Mederos . Michael A. . Reber . Howard A. . Girgis . Mark D. . Acute Pancreatitis: A Review . JAMA . 26 January 2021 . 325 . 4 . 382–390 . 10.1001/jama.2020.20317. 33496779 .
  3. Web site: Pancreatitis. Mayo Clinic. 14 October 2020.
  4. Quinlan . JD . Acute pancreatitis. . American Family Physician . 1 November 2014 . 90 . 9 . 632–9 . 25368923.
  5. Web site: Symptoms & Causes of Pancreatitis. The National Institute of Diabetes and Digestive and Kidney Diseases. 4 October 2020.
  6. Wright . William F. . Cullen Sign and Grey Turner Sign Revisited . Journal of Osteopathic Medicine . 1 June 2016 . 116 . 6 . 398–401 . 10.7556/jaoa.2016.081.
  7. Zeng . Tingting . An . Jing . Wu . Yanqiu . Hu . Xueru . An . Naer . Gao . Lijuan . Wan . Chun . Liu . Lian . Shen . Yongchun . Incidence and prognostic role of pleural effusion in patients with acute pancreatitis: a meta-analysis . Annals of Medicine . 12 December 2023 . 55 . 2 . 10.1080/07853890.2023.2285909. 10880572 .
  8. Book: Sriram Bhat M. SRB's Clinical Methods in Surgery. 2018-10-31. JP Medical Ltd. 978-93-5270-545-0. 488–.
  9. Book: https://www.ncbi.nlm.nih.gov/books/NBK6978/ . Early complications of severe acute pancreatitis . Bassi C, Falconi M, Butturini G, Pederzoli P . Surgical Treatment: Evidence-Based and Problem-Oriented. . Holzheimer RG, Mannick JA . Munich . Zuckschwerdt . 2001 .
  10. Rawla P, Sunkara T, Thandra KC, Gaduputi V . Hypertriglyceridemia-induced pancreatitis: updated review of current treatment and preventive strategies . Clinical Journal of Gastroenterology . 11 . 6 . 441–448 . December 2018 . 29923163 . 10.1007/s12328-018-0881-1 . 49311482 .
  11. Rawla P, Bandaru SS, Vellipuram AR . Review of Infectious Etiology of Acute Pancreatitis . Gastroenterology Research . 10 . 3 . 153–158 . June 2017 . 28725301 . 5505279 . 10.14740/gr858w .
  12. Chung JW, Ryu SH, Jo JH, Park JY, Lee S, Park SW, Song SY, Chung JB . Clinical implications and risk factors of acute pancreatitis after cardiac valve surgery . Yonsei Medical Journal . 54 . 1 . 154–9 . January 2013 . 23225812 . 10.3349/ymj.2013.54.1.154 . 3521256.
  13. Tenner S, Baillie J, DeWitt J, Vege SS . American College of Gastroenterology guideline: management of acute pancreatitis . The American Journal of Gastroenterology . 108 . 9 . 1400–15; 1416 . September 2013 . 23896955 . 10.1038/ajg.2013.218 . 12610145 . free .
  14. Gumaste VV, Dave PB, Weissman D, Messer J . Lipase/amylase ratio. A new index that distinguishes acute episodes of alcoholic from nonalcoholic acute pancreatitis . Gastroenterology . 101 . 5 . 1361–6 . November 1991 . 1718808 . 10.1016/0016-5085(91)90089-4 . free .
  15. Banks PA, Freeman ML . Practice guidelines in acute pancreatitis . The American Journal of Gastroenterology . 101 . 10 . 2379–400 . October 2006 . 10.1111/j.1572-0241.2006.00856.x . 17032204 . 1837007 . Practice Parameters Committee of the American College of Gastroenterology . free .
  16. UK Working Party on Acute Pancreatitis . UK guidelines for the management of acute pancreatitis . Gut . 54 . Suppl 3 . iii1–9 . May 2005 . 15831893 . 1867800 . 10.1136/gut.2004.057026 .
  17. In support of the superiority of the lipase:
    • Smith RC, Southwell-Keely J, Chesher D . Should serum pancreatic lipase replace serum amylase as a biomarker of acute pancreatitis? . ANZ Journal of Surgery . 75 . 6 . 399–404 . June 2005 . 15943725 . 10.1111/j.1445-2197.2005.03391.x . 35768001 .
    • Treacy J, Williams A, Bais R, Willson K, Worthley C, Reece J, Bessell J, Thomas D . Evaluation of amylase and lipase in the diagnosis of acute pancreatitis . ANZ Journal of Surgery . 71 . 10 . 577–82 . October 2001 . 11552931 . 10.1046/j.1445-2197.2001.02220.x . 30880859 .
    • Keim V, Teich N, Fiedler F, Hartig W, Thiele G, Mössner J . A comparison of lipase and amylase in the diagnosis of acute pancreatitis in patients with abdominal pain . Pancreas . 16 . 1 . 45–9 . January 1998 . 9436862 . 10.1097/00006676-199801000-00008 . 21285537 .

    Without support for the superiority of the lipase:

    • Ignjatović S, Majkić-Singh N, Mitrović M, Gvozdenović M . Biochemical evaluation of patients with acute pancreatitis . Clinical Chemistry and Laboratory Medicine . 38 . 11 . 1141–4 . November 2000 . 11156345 . 10.1515/CCLM.2000.173 . 34932274 .
    • Sternby B, O'Brien JF, Zinsmeister AR, DiMagno EP . What is the best biochemical test to diagnose acute pancreatitis? A prospective clinical study . Mayo Clinic Proceedings . 71 . 12 . 1138–44 . December 1996 . 8945483 . 10.4065/71.12.1138 .
  18. Smith RC, Southwell-Keely J, Chesher D . Should serum pancreatic lipase replace serum amylase as a biomarker of acute pancreatitis? . ANZ Journal of Surgery . 75 . 6 . 399–404 . June 2005 . 15943725 . 10.1111/j.1445-2197.2005.03391.x . 35768001 .
  19. Corsetti JP, Cox C, Schulz TJ, Arvan DA . Combined serum amylase and lipase determinations for diagnosis of suspected acute pancreatitis . Clinical Chemistry . 39 . 12 . 2495–9 . December 1993 . 10.1093/clinchem/39.12.2495 . 7504593 . free .
  20. Hameed AM, Lam VW, Pleass HC . Significant elevations of serum lipase not caused by pancreatitis: a systematic review . HPB . 17 . 2 . 99–112 . February 2015 . 24888393 . 4299384 . 10.1111/hpb.12277 .
  21. Bailey & Love's/24th/1123
  22. Larvin M, Chalmers AG, McMahon MJ . Dynamic contrast enhanced computed tomography: a precise technique for identifying and localising pancreatic necrosis . BMJ . 300 . 6737 . 1425–8 . June 1990 . 2379000 . 1663140 . 10.1136/bmj.300.6737.1425 .
  23. Arvanitakis M, Koustiani G, Gantzarou A, Grollios G, Tsitouridis I, Haritandi-Kouridou A, Dimitriadis A, Arvanitakis C . Staging of severity and prognosis of acute pancreatitis by computed tomography and magnetic resonance imaging-a comparative study . Digestive and Liver Disease . 39 . 5 . 473–82 . May 2007 . 17363349 . 10.1016/j.dld.2007.01.015 .
  24. Scaglione M, Casciani E, Pinto A, Andreoli C, De Vargas M, Gualdi GF . Imaging assessment of acute pancreatitis: a review . Seminars in Ultrasound, CT and MRI . 29 . 5 . 322–40 . October 2008 . 18853839 . 10.1053/j.sult.2008.06.009 .
  25. Miller FH, Keppke AL, Dalal K, Ly JN, Kamler VA, Sica GT . MRI of pancreatitis and its complications: part 1, acute pancreatitis . AJR. American Journal of Roentgenology . 183 . 6 . 1637–44 . December 2004 . 15547203 . 10.2214/ajr.183.6.01831637 .
  26. Testoni PA, Mariani A, Curioni S, Zanello A, Masci E . MRCP-secretin test-guided management of idiopathic recurrent pancreatitis: long-term outcomes . Gastrointestinal Endoscopy . 67 . 7 . 1028–34 . June 2008 . 18179795 . 10.1016/j.gie.2007.09.007 .
  27. Khalid A, Peterson M, Slivka A . Secretin-stimulated magnetic resonance pancreaticogram to assess pancreatic duct outflow obstruction in evaluation of idiopathic acute recurrent pancreatitis: a pilot study . Digestive Diseases and Sciences . 48 . 8 . 1475–81 . August 2003 . 12924639 . 10.1023/A:1024747319606 . 3066587 .
  28. IAP/APA evidence-based guidelines for the management of acute pancreatitis . Pancreatology . 13 . 4 Suppl 2 . e1–15 . 2013 . 24054878 . 10.1016/j.pan.2013.07.063 . Working Group IAP/APA Acute Pancreatitis Guidelines . free . 1854/LU-8582111 . free .
  29. Talukdar R, Swaroop Vege S . Early management of severe acute pancreatitis . Current Gastroenterology Reports . 13 . 2 . 123–30 . April 2011 . 21243452 . 10.1007/s11894-010-0174-4 . 38955726 . free .
  30. Trikudanathan G, Navaneethan U, Vege SS . Current controversies in fluid resuscitation in acute pancreatitis: a systematic review . Pancreas . 41 . 6 . 827–34 . August 2012 . 22781906 . 10.1097/MPA.0b013e31824c1598 . 1864635 .
  31. Gardner TB, Vege SS, Chari ST, Petersen BT, Topazian MD, Clain JE, Pearson RK, Levy MJ, Sarr MG . Faster rate of initial fluid resuscitation in severe acute pancreatitis diminishes in-hospital mortality . Pancreatology . 9 . 6 . 770–6 . 2009 . 20110744 . 10.1159/000210022 . 5614093 .
  32. Basurto Ona X, Rigau Comas D, Urrútia G . Opioids for acute pancreatitis pain . The Cochrane Database of Systematic Reviews . 7 . 7 . CD009179 . July 2013 . 23888429 . 10.1002/14651858.CD009179.pub2 .
  33. Helm JF, Venu RP, Geenen JE, Hogan WJ, Dodds WJ, Toouli J, Arndorfer RC . Effects of morphine on the human sphincter of Oddi . Gut . 29 . 10 . 1402–7 . October 1988 . 3197985 . 1434014 . 10.1136/gut.29.10.1402 .
  34. Al-Omran . Mohammed . AlBalawi . Zaina H . Tashkandi . Mariam F . Al-Ansary . Lubna A . Enteral versus parenteral nutrition for acute pancreatitis . Cochrane Database of Systematic Reviews . 20 January 2010 . 1 . CD002837 . 10.1002/14651858.CD002837.pub2. 20091534 . 7120370 .
  35. Crockett . Seth D. . Wani . Sachin . Gardner . Timothy B. . Falck-Ytter . Yngve . Barkun . Alan N. . Crockett . Seth . Falck-Ytter . Yngve . Feuerstein . Joseph . Flamm . Steven . Gellad . Ziad . Gerson . Lauren . Gupta . Samir . Hirano . Ikuo . Inadomi . John . Nguyen . Geoffrey C. . Rubenstein . Joel H. . Singh . Siddharth . Smalley . Walter E. . Stollman . Neil . Street . Sarah . Sultan . Shahnaz . Vege . Santhi S. . Wani . Sachin B. . Weinberg . David . American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis . Gastroenterology . March 2018 . 154 . 4 . 1096–1101 . 10.1053/j.gastro.2018.01.032. 29409760 .
  36. Besselink MG, van Santvoort HC, Boermeester MA, Nieuwenhuijs VB, van Goor H, Dejong CH, Schaapherder AF, Gooszen HG . Timing and impact of infections in acute pancreatitis . The British Journal of Surgery . 96 . 3 . 267–73 . March 2009 . 19125434 . 10.1002/bjs.6447 . 2226746 . free .
  37. Wu BU, Johannes RS, Kurtz S, Banks PA . The impact of hospital-acquired infection on outcome in acute pancreatitis . Gastroenterology . 135 . 3 . 816–20 . September 2008 . 18616944 . 2570951 . 10.1053/j.gastro.2008.05.053 .
  38. Jafri NS, Mahid SS, Idstein SR, Hornung CA, Galandiuk S . Antibiotic prophylaxis is not protective in severe acute pancreatitis: a systematic review and meta-analysis . American Journal of Surgery . 197 . 6 . 806–13 . June 2009 . 19217608 . 10.1016/j.amjsurg.2008.08.016 .
  39. Canlas KR, Branch MS . Role of endoscopic retrograde cholangiopancreatography in acute pancreatitis . World Journal of Gastroenterology . 13 . 47 . 6314–20 . December 2007 . 18081218 . 4205448 . 10.3748/wjg.v13.i47.6314 . free .
  40. Book: The Intensive Care Manual . Apostolakos MJ, Papadakos PJ . 2001 . McGraw-Hill Professional . 978-0-07-006696-0.
  41. Book: Current Obstetric & Gynecologic Diagnosis & Treatment . DeCherney AH, Lauren N . 2003 . McGraw-Hill Professional . 978-0-8385-1401-6.
  42. Book: The Trauma Manual: Trauma and Acute Care Surgery . Peitzman AB, Schwab CW, Yealy DM, Fabian TC . 2007 . Lippincott Williams & Wilkins . 978-0-7817-6275-5.
  43. Larvin M, McMahon MJ . APACHE-II score for assessment and monitoring of acute pancreatitis . Lancet . 2 . 8656 . 201–5 . July 1989 . 2568529 . 10.1016/S0140-6736(89)90381-4 . 26047869 .
  44. Yeung YP, Lam BY, Yip AW . APACHE system is better than Ranson system in the prediction of severity of acute pancreatitis . Hepatobiliary & Pancreatic Diseases International . 5 . 2 . 294–9 . May 2006 . 16698595 . dead . https://web.archive.org/web/20061026152338/http://hbpdint.com/text.asp?id=837 . 2006-10-26 .
  45. Chatzicostas C, Roussomoustakaki M, Vlachonikolis IG, Notas G, Mouzas I, Samonakis D, Kouroumalis EA . Comparison of Ranson, APACHE II and APACHE III scoring systems in acute pancreatitis . Pancreas . 25 . 4 . 331–5 . November 2002 . 12409825 . 10.1097/00006676-200211000-00002 . 27166241 .
  46. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH . Acute pancreatitis: value of CT in establishing prognosis . Radiology . 174 . 2 . 331–6 . February 1990 . 2296641 . 10.1148/radiology.174.2.2296641 .
  47. Knoepfli AS, Kinkel K, Berney T, Morel P, Becker CD, Poletti PA . Prospective study of 310 patients: can early CT predict the severity of acute pancreatitis? . Abdominal Imaging . 32 . 1 . 111–5 . 2007 . 16944038 . 10.1007/s00261-006-9034-y . 20809378 .
  48. Leung TK, Lee CM, Lin SY, Chen HC, Wang HJ, Shen LK, Chen YY . Balthazar computed tomography severity index is superior to Ranson criteria and APACHE II scoring system in predicting acute pancreatitis outcome . World Journal of Gastroenterology . 11 . 38 . 6049–52 . October 2005 . 16273623 . 4436733 . 10.3748/wjg.v11.i38.6049 . free .
  49. Vriens PW, van de Linde P, Slotema ET, Warmerdam PE, Breslau PJ . Computed tomography severity index is an early prognostic tool for acute pancreatitis . Journal of the American College of Surgeons . 201 . 4 . 497–502 . October 2005 . 16183486 . 10.1016/j.jamcollsurg.2005.06.269 .
  50. Triantopoulou C, Lytras D, Maniatis P, Chrysovergis D, Manes K, Siafas I, Papailiou J, Dervenis C . Computed tomography versus Acute Physiology and Chronic Health Evaluation II score in predicting severity of acute pancreatitis: a prospective, comparative study with statistical evaluation . Pancreas . 35 . 3 . 238–42 . October 2007 . 17895844 . 10.1097/MPA.0b013e3180619662 . 24245362 .
  51. Mortelé KJ, Mergo PJ, Taylor HM, Wiesner W, Cantisani V, Ernst MD, Kalantari BN, Ros PR . Peripancreatic vascular abnormalities complicating acute pancreatitis: contrast-enhanced helical CT findings . European Journal of Radiology . 52 . 1 . 67–72 . October 2004 . 15380848 . 10.1016/j.ejrad.2003.10.006 .
  52. Papachristou GI, Muddana V, Yadav D, O'Connell M, Sanders MK, Slivka A, Whitcomb DC . Comparison of BISAP, Ranson's, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis . The American Journal of Gastroenterology . 105 . 2 . 435–41; quiz 442 . February 2010 . 19861954 . 10.1038/ajg.2009.622 . 41655611 .
  53. Iannuzzi . Jordan P. . King . James A. . Leong . Jessica Hope . Quan . Joshua . Windsor . Joseph W. . Tanyingoh . Divine . Coward . Stephanie . Forbes . Nauzer . Heitman . Steven J. . Shaheen . Abdel-Aziz . Swain . Mark . Buie . Michael . Underwood . Fox E. . Kaplan . Gilaad G. . Global Incidence of Acute Pancreatitis Is Increasing Over Time: A Systematic Review and Meta-Analysis . Gastroenterology . January 2022 . 162 . 1 . 122–134 . 10.1053/j.gastro.2021.09.043. 34571026 .